SLPOtherDysphagia2023

Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease.

Maryann N Krasko, John Szot, Karolina Lungova and 4 others

PMID 36949296

WHAT IT FOUND

Rats modeling early Parkinson's disease chewed slower and had poor bolus control before motor signs appeared.

They also showed delayed gut transit and constipation-like changes. This confirms swallowing and gut issues are early disease markers, not just late complications.

Key findings

01Pink1-/- rats demonstrated slower mastication rates and slower pharyngoesophageal bolus speeds compared to wildtype controls.

02The mutant rats exhibited a higher percentage of abnormal swallowing behaviors, specifically compensatory head movements and stasis in the pharynx and esophagus.

03Gastrointestinal dysfunction included delayed entry of contents into the caecum and colon, fewer fecal pellets, and heavier individual pellets, despite no difference in food or water intake.

STILL TO COME

How it was doneWhat they foundWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study used an animal model, so findings cannot be directly generalized to human patients. Swallowing was assessed in a two-dimensional sagittal plane, meaning bolus area was measured instead of bolus volume. Bolus volume was not controlled because rats ate ad libitum, which may introduce variability. Gastrointestinal imaging stopped at six hours post-gavage, so full clearance of contents from the organs was not observed. Swallow and GI studies were performed on separate days, so the same bolus was not tracked from mouth to excretion.

Declared interests

The authors reported no conflicts of interest. The work was supported by the National Institutes of Health (Extramural).

The easy way to misread this

Do not interpret these rat findings as direct evidence for human diagnosis or treatment efficacy. While the model recapitulates prodromal deficits, the study demonstrates pathophysiology in animals, not clinical outcomes in patients.

Read it on PubMed →